MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Movement disorders (Parkinson’s disease) in Uzbekistan: Epidemiologic, clinical and therapeutic aspects

N. Eshakulova, A. Umarov, N. Tuychibaeva, G. Rakhimbaeva, M. Ataniyazov (Tashkent, Uzbekistan)

Meeting: 2016 International Congress

Abstract Number: 461

Keywords: Parkinsonism

Session Information

Date: Monday, June 20, 2016

Session Title: Epidemiology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: The aim was to determine the epidemiologic, clinical and therapeutic aspects of patients treated for PD.

Methods: This was a prospective and cross-sectional study conducted over 12 months on 21 patients treated for Parkinson’s disease at the Neurology department of Tashkent. The data have been collected using a pre-established form for the survey.

Results: Sex ratio was 13/8 and the mean age was 60.26 ±1.7 years. The Uzbek population was the most represented ethnic group with 47.36%. 68.42% were married. 21.05% were farmers and 63.15% had achieved the primary level education. Consanguinity was found in 42.12% cases and the use of pesticides was noted in 15.78%. The average age of onset was around 55.42 ±1.6 years. Tremor was the first functional sign (68.42%) and was present in 84.21% of patients. However, rigidity was found in 94.73% of them. The other signs were represented by motor fluctuations (79.84%), painful syndrome (72.57%), mood disorder (53.51%), hallucinations (41.13%), sleep disturbances (32.57%). Brain CT was available in five patients and was normal in four of them. 36.84% of the patients were receiving only (Levodopa + benserazide or carbidopa) or piribedil and 52.63% one of these in association with Trihexyphenidyl. 42.10% were benefiting of physiotherapy.

Conclusions: Frequency of PD signs in our setting is not different from those in western countries. It is important to educate general practitioners and people for early recognition of PD signs for a better management.

To cite this abstract in AMA style:

N. Eshakulova, A. Umarov, N. Tuychibaeva, G. Rakhimbaeva, M. Ataniyazov. Movement disorders (Parkinson’s disease) in Uzbekistan: Epidemiologic, clinical and therapeutic aspects [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/movement-disorders-parkinsons-disease-in-uzbekistan-epidemiologic-clinical-and-therapeutic-aspects/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/movement-disorders-parkinsons-disease-in-uzbekistan-epidemiologic-clinical-and-therapeutic-aspects/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley